Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D0G0UZ
|
|||
Former ID |
DIB001587
|
|||
Drug Name |
SBP-002
|
|||
Synonyms |
Coramsine; Solasonine + solamargine; Solasodine glycosides (cancer, injectable formulation), Solbec; Solasodine glycosides (psoriasis, cream formulation), Solbec; Solasonine + solamargine (cancer), Solbec; Solasonine + solamargine (psoriasis), Solbec; SBP-002 (intravenous, cancer), Solbec; SBP-002 (psoriasis, cream formulation), Solbec
Click to Show/Hide
|
|||
Indication | Melanoma [ICD-11: 2C30; ICD-9: 172] | Terminated | [1] | |
Company |
Curacel International Pty Ltd; Freedom Eye Ltd
|
|||
Structure |
Download2D MOL |
Target and Pathway | Top | |||
---|---|---|---|---|
Target(s) | Interleukin 6 receptor (IL6R) | Target Info | Modulator | [2] |
KEGG Pathway | Cytokine-cytokine receptor interaction | |||
HIF-1 signaling pathway | ||||
PI3K-Akt signaling pathway | ||||
Jak-STAT signaling pathway | ||||
Hematopoietic cell lineage | ||||
Non-alcoholic fatty liver disease (NAFLD) | ||||
Reactome | MAPK3 (ERK1) activation | |||
MAPK1 (ERK2) activation | ||||
WikiPathways | SIDS Susceptibility Pathways | |||
Senescence and Autophagy in Cancer | ||||
IL-6 signaling pathway | ||||
Differentiation Pathway | ||||
Interleukin-6 signaling |
References | Top | |||
---|---|---|---|---|
REF 1 | Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800022850) | |||
REF 2 | Drugs@FDA. U.S. Food and Drug Administration. U.S. Department of Health & Human Services. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.